CA
GBT

CHI Advisors’s Global Blood Therapeutics, Inc. GBT Stock Holding History

CHI Advisors’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-20,000
Closed -$8K – 26
2020
Q4 		$8K Buy
20,000
+10,000
+100% +$493K ﹤0.01% 23
2020
Q3 		$26K Buy
+10,000
New +$636K 0.01% 22

Other funds holding GBT

Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

CHI Advisors's GBT Position: Q2 2021 in Review

CHI Advisors sold out of Global Blood Therapeutics, Inc. (GBT) in Q2 2021, closing a stake of 15,000 shares — an estimated $611K sold.

CHI Advisors first reported a position in GBT in Q3 2019 and held it in 7 quarters. The position peaked at $1.59M in Q4 2019. 192 funds tracked by Wall St. Rank hold GBT as of Q2 2021.

  • CHI Advisors reported no remaining Global Blood Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
  • CHI Advisors sold 15,000 Global Blood Therapeutics, Inc. shares in Q2 2021, an estimated $611K.
  • CHI Advisors first reported a position in Global Blood Therapeutics, Inc. in Q3 2019 and held it in 7 quarters.
  • CHI Advisors's Global Blood Therapeutics, Inc. position peaked at $1.59M in Q4 2019.
  • 192 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q2 2021.

Based on CHI Advisors's 13F filing for Q2 2021, filed 11 Aug 2021.